Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

That they did, but that is the past.

Now all that matters is the phase 2 scar results update we will see in October 2015.

It will be 5 doses of RXI-109 on one side against untreated on the other side.

Considering the 3 doses RXI-109 look pretty good compared to placebo slide 11 of Presentation:

http://investors.rxipharma.com/Cache/1500072639.PDF?Y=&O=PDF&D=&fid=1500072639&T=&iid=4418218

The new picture results will be with 5 doses. But the trial itself is running all the way through to 6 doses. I believe the company is gonna attempt to show early good data to boost the share price before the November 5, 2015 deadline to regain compliance. With good pictures that will be easy.